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Abstract
Background: Endometriosis is a common gynecological disease, which can seriously affect the physical and mental health of patients. However,
there is not a satisfactory way to treat endometriosis with a low recurrence rate.
Materials and Methods: Including twenty patients with endometriosis given conservative surgery, a prospective clinical study was performed
with randomly grouping and positive control. The traditional Chinese medicine (TCM) and western medicine (WM) groups were given Danchi
decoction and GnRH-a or gestrinone respectively. Treatment was given in 1–5 days during the first menstruation. The eutopic endometriums
were collected before and 3 months after the treatment, respectively. Then immunohistochemistry was performed to obtain the expressions of
P450arom and survivin. In the normal control (NC) group no drugs were administered.
Results: Before the treatment, the expressions of P450arom and survivin in both TCM and WM groups were much higher than the NC group
(P<0.05) and no significant differences between the two groups (P>0.05). The expressions of the two groups were remarkably decreased after
the treatment (P<0.05) and they had no difference between the two groups (P>0.05).
Conclusion: Danchi decoction can control the recurrence of endometriosis by restraining abnormal secretion of aromatizing enzyme and
regulating cell apoptosis in eutopic endometrium. Excessive expressions of aromatizing enzyme and decreased apoptosis are a possible
mechanism of endometriosis recurrence.
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Introduction
Endometriosis with the symptoms of progressive dysmenorrhea, chronic pelvic pain, deep dyspareunia, infertility, menstrual abnormalities,
and aggravated pelvic can seriously affect the physical and mental health of patients (Liu and Lang, 2011; Sun et al., 2011; Zhou and Qu, 2009;
Zhou et al., 2012). It is a common gynecological disease and recently its occurrence rate is increasing (Sun et al., 2011; Zhou and Qu, 2009).
Endometriosis has a few malignant biological behaviors such as wide cultivation, invasion, destruction, unlimited proliferation, and metastasis,
which therefore is considered as a kind of “benign tumor”.
The etiology of endometriosis is not clear due to the complex pathogenesis (Liu and Lang, 2011; Zhao et al. 2013a). A theory of Sampson’s
blood reflux inducing endometrial implantation can explain part of endometriosis etiology. This theory was improved by Lang (2003) with an
idea of “the eutopic endometrium determinism”, which was based on the fact that the biological characteristics of the eutopic endometrium of
patients with endometriosis are different from those of normal women. Aromatase cytochrome P450 (P450arom) as well as the apoptosis
inhibitory protein and survivin were found to be abnormally expressed in the eutopic endometrium (Lang, 2003).
Currently, conservative surgery is the most popular way to treat endometriosis and however, its overall recurrence rate is as high as 30.4%
(Koga et al., 2006). The recurrence rate can be reduced if some drugs, e.g., GnRH-a or gestrinone, are taken for 3–6 months in company with the
surgery. But these drugs have serious side effects such as hot flashes, sleeplessness, vaginal dryness, joint pain, headache, breakthrough bleeding,
bone loss, and liver and kidney damage (Lang, 2005). In particular, this approach affects the fertility of women. Therefore, it is necessary to find
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a safe and effective drug to treat endometriosis and reduce its recurrence.
One could achieve such a drug from Traditional Chinese medicines (TCM). Many existing investigations (Cao et al.,2008; Lian et al., 2007;
Qi et al., 2011; Song et al., 2005; Yang et al., 2006; Yang et al. 2012; Zhao et al. 2013a and 2013b) showed that TCM can alleviate endometriosis
symptoms or improve signs with slight side effects. This can be explained according to the theory of TCM and the physiological and
pathological features of females. The etiology of endometriosis is blood stasis (Zhou and Qu, 2009) and qi stagnation is the leading cause of the
blood stasis. Therefore, one can study endometriosis through the qi stagnation and blood stasis. In this paper, we investigated the effect of
Danchi decoction on qi stagnation and blood stasis after conservative surgery and explored a possible mechanism of endometriosis recurrence.
Materials and Methods
Object of study
Twenty patients accepted laparoscopic conservative surgeries at Guanganmen Hospital, China Academy of Chinese Medical Sciences and
Beijing Friendship Hospital, Capital Medical University from January 2010 to February 2012. They were confirmed to have ovarian
endometriosis cysts and blood stasis caused by qi stagnation. The choosing standards are as follows:
1) The ones following the laparoscopic diagnosis standard and the pathological criteria for the endometriosis diagnosis were classified to
pathological type of ovary endometriosis. 2) Before surgery they had belonged to qi stagnation and blood stasis type (premenstrual abdominal
pain, menstrual pain, hard menstruation, blood clots, and pain-reduction after block discharge, anal bulge, premenstrual breast pain, and chest
discomfort; as well as dark purple tongue with petechiae, white moss, and string pulse at the tongue edge). 3) They underwent endometriosis
laparotomy or laparoscopy surgery for the first time. 4) Any drug treating endometriosis or its recurrence cannot be taken in half a year before
surgery. 5) They had no plan of pregnancy in half a year after surgery. 6) They had no autoimmune diseases; cardiovascular, liver and kidney
diseases; diseases of hematopoietic system; other serious primary diseases; or mental diseases. 7) They were 18~48 years old and not lactating or
pregnant. 8) All of them signed the informed consent.
The excluding standard include the following:
1) They were found to also have estrogen adenomyosis, myoma of uterus, endometrial lesion, polycystic ovary syndrome, genital cancer, breast
cancer, estrogen dependent disease, tumor, or acute inflammation.2) After the operation, they used any drugs to treat of the current disease.
In addition, 5 more patients were chosen as the normal control group:
1) They had accepted laparoscopic ovarian cyst surgery and been diagnosed as ovarian cyst after surgery. They had also been excluded to have
endometriosis or malignant tumors; 2) The eutopic endometriums had been collected before surgery and diagnosed to be normal; 3) Any drug
treating endometriosis or its recurrence cannot be taken in half a year before surgery; 4) They were 18~48 years old and not lactating or
pregnant.
Treatment Methods
After the conservative surgery, the patients with qi stagnation and blood stasis type of endometriosis were randomly divided into TCM and
WM groups. Before the current study, we had been approved by the ethics committee of our hospital. Ethics number is No.57 of Guanganmen
hospital, China Academy of traditional Chinese medicine in 2009. The diagnostic criteria of endometriosis of qi stagnation and blood stasis type
can be found in references (Cao, 2004; Ministry, 1993).
Traditional Chinese Medicine Group: the patients began to take Danchi decoction in the first 1–5 days during menstruation. They took
one oral dose per day in the form of a decoction in water. A dose was divided into two bags (200 ml one bag) which were taken in the morning
and evening, respectively, within 1 hour after a meal. This treatment course lasted 3 months without stopping even during menstruation. The
Danchi decoction was provided by the manufacturing laboratory, Guanganmen Hospital, China Academy of Traditional Chinese Medicine. It
was composed of: 25 g Radix salviae miltiorrhizae, 15 g Radix paeoniae rubra, 10 g Radix Bupleuri, 15 g Nutagrass flatsedge rhizome, 10 g
zedoary, and 15 g spina Gleditsiae. Note that the Danchi decoction is a safe drug as had been examined in our previous project: the "Eleventh
Five" National Technology Support Program project (No.2006BAI04A17).
Yang et al., Afr J Tradit Complement Altern Med. (2015) 12(4):65-71
http://dx.doi.org/10.4314/ajtcam.v12i4.10
67
Western Medicine Group. The patients began to take gonadotropin-releasing hormone agonist (GnRH-a) or gestrinone capsules in the
first 1–5 days during menstruation. GnRH-a（Goserelin, Zoladex） of 3.6 mg in a dose was hypodermically administered once a month and for 3
months. Gestrinone of 2.5 mg in a dose was orally taken twice a week and for 3 months. GnRH-a were purchased from Beijing Baoyuan
Medicines Company, Beijing, China (national medicine accurate: H35020520). Gestrinone capsules were purchased from Beijing Zizhu
Pharmaceutical Co., Ltd., Beijing, China (national medicine accurate: H19980020).
Normal Control Group. No drugs were administered in the normal control group.
Sample Collection and Processing
In both TCM and WM groups, endometrial tissues were collected before surgery and 3 months after drug withdrawal. In the NC group
endometrial tissues were collected before surgery. First, 1–2 g endometrial tissue was collected by an endometrial collector from the posterior
wall of the uterus. Next, the tissue samples were immediately washed triple with a phosphate-buffered solution, fixed in another solution with
10% neutral formaldehyde for 24 hours, and then preserved at normal temperatures after paraffin embedding.
Immunohistochemistry
Then, immunohistochemistry was used to detect P450arom and survivin expressions in the 25 specimens. Color reaction in the cytoplasm
of tissue slices was observed under an optical microscope, where the positive signals of P450arom and survivin show pale yellow, yellow, brown
yellow, or brown. In each section, three visual fields were randomly chosen to be photographed. A professional image analysis system,
Image-Pro Plus5.1, was employed to analyze the visual fields semi-quantitatively. Integrated optical densities (IOD) are used as evaluation
parameters of P450arom and survivin expression intensities, where IOD = average optical density (AOD) × positive area (A). These measures
were implemented by the same researcher with the same instrument, light, white balance, and other parameters for each section.
Statistical Methods
We analyzed all experimental data obtained by the statistical software SPSS17.0. All measurement data were first expressed as x ±s.
When the data obeyed a normal distribution and the variance homogeneity, multiple samples with a single factor analysis of variance would be
applied and a paired t-test would be used for the comparison within a group before and after treatment. If the data did not obey a normal
distribution or the variance homogeneity, a rank sum test would be used. We used bilateral inspection with the inspection level of α=0.05. 
Therefore, the significance was set at P<0.05.
Results
There were 29 cases first chosen in this study, among which 25 cases were finally taken: 10 ones in the TCM and WM groups, respectively,
and 5 ones in the NC group. We had compared the three groups in the ages and times of pregnancy and birth and had not found a statistical
difference (P > 0.05), as seen in Table 1.
Table 1: Comparison of general data among the three groups ( x  s )
Group Case Age (year) pregnancy time birth time
NC 5 34.81±7.30 0.89±0.92 0.48±0.52
TCM 10 33.35±5.52 0.90±1.03 0.50±0.61
WM 10 34.09±7.41 1.01±1.40 0.49±0.66
P 0.861 0.938 0.820
Expression of P450arom
The cytoplasm aromatase cytochrome P450 exists only in the endometrial glandular epithelium and therefore has no expression in the cell
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nucleus or membrane and has weak coloring in mesenchymal cells. In Fig. 1E it showed no or low expressions in normal endometrium cells and
in Figs. 1A–1D it illustrated positive expressions in eutopic endometrium cells. One can see in Table 2 that both TCM and WM groups showed
positive signals of IOD in immunohistochemistry staining and the expressions of P450arom in preoperative eutopic endometriums were
significantly higher than that in the NC group (P=0.000 and P=0.000 for the TCM and WM groups, respectively). Between the TCM and WM
groups there was no significant difference (P=0.541). Three months after drug withdrawal in both TCM and WM groups, the P450arom
expressions were lower than those before surgery (P=0.005 and P=0.012, respectively), as displayed in Table 3. The expressions among the
TCM, WM, and NC groups had no significant difference (P=0.146), as shown in Table 4.
Table 2: Integrated optical densities of P450arom in preoperative eutopic endometrium in different groups
Group Case P450arom
TCM 10 2119.53±170.31△
WM 10 2077.98±143.81△
NC 5 1671.22±105.82
Note: △ denotes a comparison with the NC group. The significant difference was taken as P<0.05.
Table 3: Integrated optical densities of P450arom in eutopic endometrium before surgery and after drug withdrawal in different groups
Group Cases
P450arom
Preoperation After drug withdrawal
TCM 10 2119.53±170.31 1823.44±128.18△
WM 10 2077.98±143.81 1819.86±201.49△
Note: △ denotes a comparison with preoperation. The significant difference was taken as P<0.05.
Table 4: Integrated optical densities of P450arom in eutopic endometrium after drug withdrawal in different groups
Group Case P450arom
TCM 10 1823.44±128.18
WM 10 1819.86±201.49
NC 5 1671.22±105.82
Expression of Survivin
Survivin has expressions mainly in the endometrial glandular epithelial cytoplasm and the nucleus. Low expressions were appeared in
normal endometrium in Fig. 2E and positive expressions in Figs. 2A–2D. One can see in Table 5 that both TCM and WM groups showed
positive signals of IOD in immunohistochemistry staining and the expressions of survivin in the preoperative endometrium eutopic endometrium
were significantly higher than that in the NC group (P=0.02 and P=0.00 for the TCM and WM groups, respectively). Between the TCM and WM
groups there was no significant difference (P=0.80). Three months after drug withdrawal in both TCM and WM groups, the survivin expressions
were lower than that before surgery (P=0.014 and P=0.032, respectively), as illustrated in Table 6. The expressions among the TCM, WM, and
NC groups showed no significant differences (P=0.104), as observed in Table 7.
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Table 5: Integrated optical densities of survivin in preoperative eutopic endometrium in different groups
Group Case Survivin
TCM 10 1731.71±146.14△
WM 10 1781.31±182.37△
NC 5 1387.08±77.08
Note: △ denotes a comparison with the NC group. The significant difference was taken as P<0.05.
Table 6: Integrated optical densities of survivin in eutopic endometrium before surgery and after drug withdrawal in different groups
Group Case
Survivin
Preoperation After drug withdrawal
TCM 10 1731.71±146.14 1535.43±88.78△
WM 10 1781.31±182.37 1539.74±288.36△
Note: △ denotes a comparison with preoperation. The significant difference was taken as P<0.05.
Table 7: Integrated optical densities of survivin in eutopic endometrium after drug withdrawal in different groups
Group Case Survivin
TCM 10 1535.43±88.78
WM 10 1539.74±288.36
NC 5 1387.08±77.08
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Figure 1: Immunohistochemical staining of P450arom under the microscope (×200). A: TCM group before surgery; B: WM group before
surgery; C: TCM group after drug withdrawal; D: WM group after drug withdrawal; E: NC group.
Discussion
Endometriosis is a disease in which abnormal expression of aromatase causes the growth of local estrogen concentrations (Qiu and Zhang,
2008). Aromatase cytochrome P450 is the rate limiting enzyme in the final step in estrogen synthesis. With it the androstenedione and
testosterone are converted into the estrone and estradiol. Smuc et al. (2007) found that the aromatase cytochrome levels are quite low in the
normal endometrial ovarian tissues and the levels are significantly enhanced in the ectopic tissues. In the regions with high expressions of
P450arom, estrogen receptor contents are also increased.
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In our study the P450arom expressions in the TCM and WM groups before surgery were higher than that in the NC group (P<0.05), i.e.,
the P450arom expression in normal endometrium was low and it was enhanced in ectopic one. This is because local estrogen production is
grown in endometriosis. Therefore, endometriosis depends strongly on estrogen. Three months after treatment and drug withdrawal, the
expressions of P450arom were significantly decreased in both TCM and WM groups (P<0.05). There also were no differences (P>0.05) in the
expressions of P450arom among the TCM, WM, and NC groups, suggesting that the Danchi decoction has a long-term effect on the P450arom
by weakening the eutopic endometrium estrogen synthesis of local lesions. It was also indicated that Danchi decoction has roughly the same
effect as the western medicines used.
A B C
D E
Figure 2: Immunohistochemical staining of survivin under the microscope (×200). A: TCM group before surgery; B: WM group before surgery;
C: TCM group after drug withdrawal; D: WM group after drug withdrawal; E: NC group.
Abnormal apoptosis may be related to occurrence of endometriosis. Apoptosis is a controllable process of cell death in multicellular
organisms that can remove excess cells without causing inflammation. Periodic endometrial hyperplasia and shedding proceeds via cell
proliferation and apoptosis. Exfoliated endometrial fragments, due to regulation by cell apoptosis, lose the proliferative ability and stop growing,
which maintains the normal structure and function of tissues and organs. Therefore, the spontaneous apoptosis of endometrial cells is important
to maintaining a normal structure of the endometrium. However, if the apoptosis is inhibited, ectopic endometrium may survive in the pelvic
cavity causing the development of endometriosis. Compared with the normal endometrium, cell apoptosis in the eutopic endometrium is
significantly reduced. Survivin is an apoptosis inhibitory protein and may be the strongest one. It can inhibit cell apoptosis and therefore promote
cell proliferation, regulate cell mitosis, and indirectly promote angiogenesis by inhibiting the apoptosis of vascular endothelial cells. Thanks to
these characteristics different from other proteins, it has attracted wide interest. Investigations of Ueda et al. (2002) showed that the expression
of survivin in ectopic lesions of the endometrium was higher than that in the normal one. They also found that the expression of survivin in
pigmented lesions was higher than the non-pigmented lesions. This suggests that up-regulation of survivin has a positive correlation with
endometriosis infiltration and growth.
In our study, the survivin expressions in the TCM and WM groups before surgery were higher than that in the NC group (P<0.05), i.e., the
apoptosis rate in ectopic endometrium was lower than that in normal one. Therefore, cells can grow and survive in the pelvic cavity, explaining
that endometriosis has the same proliferation properties as tumors. This result was consistent with the reference (Zhang and Shen, 2006). Three
months after treatment and drug withdrawal, the expression of survivin were significantly decreased in both TCM and WM groups (P<0.05).
There also were no significant differences (P > 0.05) in the expressions of survivin among the TCM, WM, and NC groups, suggesting the
Danchi decoction can strengthen cell apoptosis.
The previous results on P450arom and survivin indicated that excessive expressions of aromatase and reduction of cell apoptosis in eutopic
endometrium may be one of the mechanisms of endometriosis recurrence. Therefore, one could take drugs to inhibit aromatase and promote cell
apoptosis to decrease endometriosis recurrence.
Conclusions
Our investigations showed that high expressions of P450arom and survivin in the eutopic endometriums were closely associated with both
occurrence and recurrence of endometriosis. Therefore, the P450arom and survivin could be considered as two important indicators in the
treatment of endometriosis. It was also shown that the Danchi decoction can inhibit endometriosis recurrence by regulating the abnormal
expressions of P450arom and survivin.
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